Taking people in EgyptPhase 3
Tests rupatadine and montelukast in people with rheumatoid arthritis
Tests two drugs, rupatadine and montelukast, in adults with rheumatoid arthritis.
Key facts
- Who runs it
- Sherief Abd-Elsalam
- Where
- Tanta, EgyptSee the site
- Trial code
- Registry title
- Effect of Some Drugs on Rheumatoid Arithritis Activity
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 75 people, planned
- Started
- 1 Oct 2018
- Expected to end
- Oct 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Rupatadine
- Montelukast
- Record updated
- 10 December 2018
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with rheumatoid arthritis. It studies the effect of rupatadine and montelukast on the disease.
- Age
- 18 years or older
- Sex
- Men and women can join
- Disease stage
- Rheumatoid arthritis (no stage or severity is given)
Main reasons for not taking part
- Liver disease
- Kidney disease
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Rheumatoid arthritis
Who cannot take part
- liver or renal disease
Where in Egypt
- Sherief Abd-ElsalamTanta, EgyptContact: Fedaa Kotkata, MscTaking people
About the trial
What the trial wants to find out
Effect of Some Drugs on Rheumatoid Arithritis Activity.
The 3 groups in the trial
- No interventionNo study treatment, for comparison
- RupatadineExisting treatment, for comparison
Rupatadine 10 mg once daily.
- MontelukastExisting treatment, for comparison
Montelukast 10 mg daily
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Clinical Study Evaluating the Effect of Histamine 1 Receptor Antagonist and Leukotreine Receptor Antagonist on Patients With Rheumatoid Arithritis
- Plain-language title
- Tests rupatadine and montelukast in people with rheumatoid arthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 10 December 2018